Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ZALCITABINE Cause Dyslipidaemia? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Dyslipidaemia have been filed in association with ZALCITABINE. This represents 12.6% of all adverse event reports for ZALCITABINE.

13
Reports of Dyslipidaemia with ZALCITABINE
12.6%
of all ZALCITABINE reports
0
Deaths
7
Hospitalizations

How Dangerous Is Dyslipidaemia From ZALCITABINE?

Of the 13 reports, 7 (53.8%) required hospitalization.

Is Dyslipidaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ZALCITABINE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does ZALCITABINE Cause?

Virologic failure (25) Treatment failure (22) Viral mutation identified (21) Pathogen resistance (18) Mitochondrial myopathy (17) Drug ineffective (14) Drug resistance (13) Hypertension (13) Pyrexia (13) Kaposi's sarcoma (11)

What Other Drugs Cause Dyslipidaemia?

OLANZAPINE (230) ROSUVASTATIN (206) ARIPIPRAZOLE (185) METHOTREXATE (175) QUETIAPINE (161) ATORVASTATIN (155) RISPERIDONE (154) METFORMIN (151) TACROLIMUS (149) ZIPRASIDONE (149)

Which ZALCITABINE Alternatives Have Lower Dyslipidaemia Risk?

ZALCITABINE vs ZALEPLON ZALCITABINE vs ZANAMIVIR ZALCITABINE vs ZANIDATAMAB ZALCITABINE vs ZANTAC ZALCITABINE vs ZANTAC 150

Related Pages

ZALCITABINE Full Profile All Dyslipidaemia Reports All Drugs Causing Dyslipidaemia ZALCITABINE Demographics